Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.

@article{Kroon2009SafetyAE,
  title={Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.},
  author={Hidde Maarten Kroon and D-Yin Lin and Peter C. A. Kam and John F Thompson},
  journal={Annals of surgery},
  year={2009},
  volume={249 6},
  pages={
          1008-13
        }
}
INTRODUCTION The treatment of elderly patients with advanced metastatic melanoma confined to a limb remains controversial. Isolated limb infusion (ILI) is an effective minimally invasive alternative to isolated limb perfusion (ILP) and is therefore a potentially valuable therapeutic option for this group. METHODS From our prospective database 185 patients with advanced metastatic melanoma of the limb treated with a single ILI between 1992 and 2007 were identified. In all patients a cytotoxic… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma

Lesly A. Dossett, Ilan Ben-Shabat, Roger Olofsson Bagge, Jonathan S. Zager
  • Annals of Surgical Oncology
  • 2016

Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

  • Journal of the National Comprehensive Cancer Network : JNCCN
  • 2016

Is Melphalan Dose Adjustment According to Ideal Body Weight Useful in Isolated Limb Infusion for Melanoma?

Anna M. Huismans, Hidde M. Kroon, Lauren E. Haydu, Peter C. A. Kam, John F. Thompson
  • Annals of Surgical Oncology
  • 2012
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers

Loading similar papers…